International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.10076904
Original Article
A Study on Feto-Maternal Outcome In Antepartum Eclampsia At GMH Sultan bazaar ,A Tertiary Care Hospital
 ,
 ,
Published
Oct. 31, 2023
Abstract

Eclampsia is defined as women with pre-eclampsia and a convulsion that cannot be attributed to other causes1. Eclampsia is one of the obstetric emergencies where resuscitation plays an important role and requires regular drills to optimise management. Hypertensive disorders of pregnancy has been one of the most important causes of morbidity and mortality worldwide in recent years2, 3. However in majority of the cases eclampsia is preceded by features of pre-eclampsia, imminent eclampsia and found to be more in rural population, young age, unbooked cases and primigravida2,3,4.

The need of the hour is to educate the women and health care workers regarding regular antenatal checkups, frequent BP monitoring, a good knowledge about high-risk symptoms and signs for good pregnancy outcome and to avoid maternal and foetal complications. This can be done with the help of flipcharts, pictures, information reflex and educational videos. The strengthening of existing health care facilities, timely referral system and transportation facilities helps in reducing morbidity and mortality. Appropriate anti-hypertensive management, administration of MgSO4 before referral at any health care facility, timely delivery, fluid management will ensure a good outcome in eclampsia.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
1594 Views
95 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved